| T1D | HC | P value* |
---|---|---|---|
Sample size, n | 121 | 120 | Â |
Age, years | 28.5 (8–53) | 29.4 (24–49) | 0.75 |
Gender, female(n%) | 71 (58.68%) | 72 (60.00%) | 0.83 |
Duration, years | 7 (0–39) | – |  |
Fasting venous blood glucose (mmol/L) | 11.9 (3.99–22.31) | – |  |
Cr (umol/L) | 56.19 (26.00–314.00) | – |  |
BUN (umol/L) | 4.43 (1.40–21.50) | – |  |
UA (umol/L) | 275.68 (81.00–540.00) | – |  |
ALT (IU/L) | 28.90 (1.00–414.00) | – |  |
AST (IU/L) | 21.32 (6.00–137.00) | – |  |
TC (mmol/L) | 4.42 (0.81–10.91) | – |  |
TG (mmol/L) | 1.09 (0.21–5.97) | – |  |
LDL (mmol/L) | 2.63 (1.10–7.37) | – |  |
HDL (mmol/L) | 1.52 (0.71–2.82) | – |  |
HbA1c (%) | 9.07% (5.30–18.4%) | – |  |
Fasting C-peptide 0 min (ng/ml) | 1.62(< 0.01–35.00) |  |  |
Fasting C-peptide 120 min (ng/ml) | 0.59(< 0.01–2.27) | – |  |
Anti-ICA positive(%)# | 18 (28.57%) | – |  |
Anti-GAD positive(%)# | 25 (39.68%) | – |  |
Anti-IAA positive(%)# | 7 (11.11%) | – |  |
Ketosis | 51 (42.15%) | – |  |
IFN-γ (pg/ml) | 3.07 (0–19.30) | – |  |
IL-6(pg/ml) | 4.16 (0–15.63) | – |  |
TNF-α (pg/ml) | 1.46 (0–17.23) | – |  |